Chemoprevention of hepatocellular carcinoma in hepatitis C virus-related cirrhosis: First, eliminate the virus

Journal of Hepatology

Volumn 34, Issue 4, 2001, Pages 606-609

  Valla, Dominique Charles ^a   Degos, Françoise ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT INTERFERON;

CHEMOPROPHYLAXIS; EDITORIAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER FAILURE; PRIORITY JOURNAL; RECURRENCE RISK; VIRUS INHIBITION;

ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS;

EID: 0035059636     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(01)00043-5     Document Type: Editorial

References (40)

1. Main causes of death in cirrhosis
2. Compensated cirrhosis: Natural history and prognostic factors
3. Survival and prognostic indicators in compensated and decompensated cirrhosis
4. Long-term prognosis and prognostic factors of liver cirrhosis in the 1980s
5. Modeling the hepatitis C virus epidemic in France
6. Time trends and age-period-cohort effects on the incidence of primary liver cancer in a well-defined French population: 1976-1995
7. Rising incidence of hepatocellular carcinoma in the United States
8. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis
9. Liver resection or transplantation for hepatocellular carcinoma. Retrospective analysis of 215 patients with cirrhosis
10. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma
11. Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma
12. Can a vitamin prevent hepatocellular carcinoma
13. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma
14. Alcoholic liver disease: Natural history, diagnosis, clinical features, evaluation, management, prognosis, and prevention
15. Predictive factor for postoperative recurrence of hepatocellular carcinoma
16. Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: A case control study in Italy
17. Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis
18. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study
19. A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis
20. Hepatocellular carcinoma arising in the absence of cirrhosis in genetic haemochromatosis: Three case reports and review of the literature
21. Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: An evidence-based approach
22. Significance of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Result of multivariate analysis
23. Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma
24. Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C
25. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice
26. Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis
27. Peginterferon alpha 2b plus ribavirin compared to interferon alpha 2b plus ribavirin for the treatment of chronic hepatitis C: 24 week treatment analysis of a multicenter, multinational phase III randomized controlled trial
28. Hepatitis C virus related cirrhosis: Time to occurrence of hepatocellular carcinoma and death
29. Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines
30. Fibrosis in patients with chronic hepatitis C: Detection and significance
31. Recovery, persistence, and sequelae in hepatitis C virus infection: A perspective on long term outcome
32. Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C
33. High malignancy of hepatocellular carcinoma in alcoholic patients with hepatitis C virus
34. Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice
35. Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1
36. Effect of interferon-alpha on progression of cirrhosis to hepatocellular carcinoma: A retrospective cohort study
37. HCV-associated liver cancer without cirrhosis
38. Hepatocellular carcinoma occurring in non-fibrotic liver: Epidemiologic and histopathologic analysis of 80 French cases
39. Hepatitis B immunisation in Singapore
40. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children